≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Graves ophthalmopathy

Endpoint Browser PheWeb

GRAVES_OPHT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • H7_LACRIMALORBITINOTH
912

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

894

4. Check minimum number of events

None

894

5. Include endpoints

None

894

6. Filter based on genotype QC (FinnGen only)

894

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4440 3590 832
Only index persons 4309 3510 799
Unadjusted period prevalence (%)
Whole population 0.09 0.10 0.02
Only index persons 0.11 0.13 0.03
Median age at first event (years)
Whole population 50.59 50.50 51.24
Only index persons 50.44 50.39 50.67

-FinnGen-

Key figures

All Female Male
Number of individuals 894 733 161
Unadjusted period prevalence (%) 0.22 0.25 0.07
Median age at first event (years) 51.25 50.65 54.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
792
Matched controls
7920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03BB01
ATC
carbimazole; oral
189.7
323.0
627
155
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
504.4
323.0
691
106
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
323.0
676
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
87.1
323.0
416
99
H03AA01
ATC
levothyroxine sodium; systemic
21.1
297.0
652
1431
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
3124.0
261.4
238
*
BAA60
NOMESCO Finland
Total thyroidectomy
50.0
229.0
277
84
H062, E050
ICD-10 Finland
NA
+∞
213.4
195
*
104
Kela drug reimbursment
Thyroid insufficiency
12.8
155.0
307
374
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
40.7
154.4
195
63
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
7.3
137.0
608
2474
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
+∞
119.9
112
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
45.4
97.6
120
31
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.8
92.1
472
1865
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
54.2
90.9
108
23
C07AA05
ATC
propranolol; systemic
5.0
84.2
344
1045
H05.2
ICD-10 Finland
Exophthalmic conditions
160.5
82.8
86
6
H53.2
ICD-10 Finland
Diplopia
18.6
81.6
129
82
H50.2
ICD-10 Finland
Vertical strabismus
43.0
63.0
78
20
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
43.4
60.7
75
19
H02AB06
ATC
prednisolone; systemic
3.2
53.3
503
2774
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.0
51.7
186
456
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
50.6
48
*
XCK00
NOMESCO Finland
Perimetry
6.2
49.0
142
268
ZX120
NOMESCO Finland
Intravenous
4.5
39.7
157
415
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
37.7
216
783
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
36.5
109
210
CEC00
NOMESCO Finland
Recession of extraocular muscle
61.6
35.5
41
7
CAC44
NOMESCO Finland
Combined decompression of orbit
+∞
34.6
33
*
CA1AD
NOMESCO Finland
Orbita CT
79.8
34.1
38
5
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
340.6
33.1
33
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
14.7
32.6
55
40
H50.0
ICD-10 Finland
Convergent concomitant strabismus
40.9
31.5
39
10
H50.6
ICD-10 Finland
Mechanical strabismus
161.0
29.9
31
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
11.1
29.7
57
55
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.2
28.4
173
639
ZXA10
NOMESCO Finland
Bilateral
2.8
27.9
215
930
H50.8
ICD-10 Finland
Other specified strabismus
103.8
27.8
30
*
A02BC02
ATC
pantoprazole; systemic
2.4
27.5
579
4204
E03.89
ICD-10 Finland
Other specified hypothyroidism
5.9
27.1
79
147
T85
ICPC
Hyperthyroidism/thyrotoxicosis
28.9
26.9
36
13
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
26.8
149
516
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
26.2
25
*
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
26.2
25
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
25.8
216
975
WF099
NOMESCO Finland
Other radiotherapy
26.1
25.5
35
14
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
69.7
23.9
27
*
C07AB07
ATC
bisoprolol; oral
2.2
23.8
384
2387
XCD10
NOMESCO Finland
Electrophysiological examination of eye
7.4
23.6
57
82
T86
ICPC
Hypothyroidism/myxoedema
4.9
22.7
77
170
H02AB07
ATC
prednisone; oral
2.8
21.8
162
674
2AB04
NOMESCO Finland
NA
44.7
21.5
26
6
E03
ICD-10 Finland
Other hypothyroidism
3.8
20.4
90
257
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.1
20.3
122
440
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
49.4
20.2
24
5
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
9.6
18.3
37
40
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
53.8
18.0
21
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.7
17.8
61
137
XCK10
NOMESCO Finland
Photography of fundus of eye
3.0
17.1
106
389
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.2
17.0
53
107
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
26.2
17.0
23
9
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.3
16.3
50
99
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
16.3
245
1418
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
21.5
16.0
23
11
E05.5
ICD-10 Finland
Thyroid crisis or storm
61.3
15.8
18
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
34.1
15.8
20
6
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
13.3
15.8
27
21
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
163.1
15.5
16
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
152.7
14.5
15
*
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
27.7
14.3
19
7
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
13.9
88
328
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
13.5
335
2288
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
9.3
13.3
27
30
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
40.8
13.2
16
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
12.5
66
217
A11CC03
ATC
alfacalcidol; systemic
6.1
12.4
33
56
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
6.5
12.2
31
49
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
10.3
12.0
23
23
E05.89
ICD-10 Finland
Other thyrotoxicosis
21.7
12.0
17
8
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.8
12.0
276
1824
CS494
NOMESCO Finland
Other visual field testing
5.6
11.9
34
63
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.1
11.8
67
231
N05CF01
ATC
zopiclone; oral
1.8
11.7
270
1783
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
5.0
11.4
36
75
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
35.6
11.3
14
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
28.4
10.7
14
5
1XC02
NOMESCO Finland
NA
11.4
10.6
19
17
WF002
NOMESCO Finland
Radical radiotherapy
3.8
10.1
42
115
106
Kela drug reimbursment
Hypoparathyroidism
17.0
9.9
15
9
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
17.0
9.9
15
9
H57.1
ICD-10 Finland
Ocular pain
3.7
9.9
42
118
H03BA02
ATC
propylthiouracil; oral
26.4
9.8
13
5
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.0
9.8
137
756
CE2W4
NOMESCO Finland
Eye movement mapping
22.0
9.4
13
6
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
9.3
180
1111
A11CC02
ATC
dihydrotachysterol; oral
24.3
8.9
12
5
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
8.3
8.6
18
22
WX002
NOMESCO Finland
Sedation and analgesia
1.8
8.5
159
965
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
8.0
8.4
18
23
S01KA02
ATC
hypromellose; ophthalmic
4.7
8.4
27
59
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.7
8.2
13
9
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.6
8.2
18
24
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
9.0
8.1
16
18
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.6
7.8
16
19
H02AB09
ATC
hydrocortisone; systemic
4.3
7.7
27
65
WX402
NOMESCO Finland
General anaesthesia
1.8
7.6
137
820
CA1BD
NOMESCO Finland
Extensive orbita CT
25.3
7.6
10
*
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
25.3
7.6
10
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
7.4
61
268
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
+∞
7.3
7
*
XCH00
NOMESCO Finland
Eye pressure measurement
3.1
7.1
36
118
ZXC95
NOMESCO Finland
Use of surgical navigator
6.1
7.1
18
30
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
12.2
7.1
12
10
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.9
91
489
H50.52
ICD-10 Finland
Exophoria
6.8
6.8
16
24
CD2S4
NOMESCO Finland
Photography of eye
11.1
6.8
12
11
WX140
NOMESCO Finland
Parabulbar anesthesy
3.0
6.7
36
124
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.6
172
1147
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.9
6.6
25
65
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.4
6.5
29
87
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
6.4
82
436
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
70.4
6.4
7
*
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
14.4
6.4
10
7
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.8
6.3
37
134
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
H50.9
ICD-10 Finland
Strabismus, unspecified
26.9
6.2
8
*
ZXA00
NOMESCO Finland
Right side
1.6
6.2
194
1357
H01CB02
ATC
octreotide; parenteral
12.6
6.1
10
8
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
8.7
6.1
12
14

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
441
534
15.32
307.65
7.7
3.1
pmol/l
4.6
4.5
0.30
417
468
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
455
230
39.25
307.65
5.1
1.7
iu/l
6.0
4.9
0.63
320
78
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
871
6271
16.12
67.11
14.8
4.3
pmol/l
15.8
14.6
35.50
840
5754
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
196
637
3.66
50.72
1.4
1.2
iu/ml
231.6
146.3
1.83
87
267
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
570
3633
2.57
39.57
7.1
6.1
mmol/l
1.2
1.2
1.96
485
3054
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
874
7251
10.18
35.04
16.2
5.1
mu/l
1.6
2.0
1.78
845
6682
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
518
3291
2.36
34.20
6.1
5.3
mmol/l
1.2
1.2
1.60
485
2968
(3018418) pH of Serum or Plasma
377
2181
2.26
29.93
4.5
3.7
ph
7.4
7.4
2.50
69
406
(3013650) Neutrophils [#/volume] in Blood by Automated count
620
4422
2.31
28.92
8.9
8.9
e9/l
3.8
4.0
0.82
542
3883
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
149
577
2.90
27.74
2.9
3.6
ng/l
52.6
81.1
9.55
135
514
(3015377) Calcium [Moles/volume] in Serum or Plasma
414
2566
2.14
26.86
3.3
3.3
mmol/l
2.3
2.4
3.47
367
2253
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
490
3338
2.04
23.61
2.7
2.3
nmol/l
77.4
78.1
0.23
451
3005
(3022096) Basophils/100 leukocytes in Blood
487
3395
1.95
21.04
5.7
5.9
%
0.7
0.7
0.33
457
3148
(3002030) Lymphocytes/100 leukocytes in Blood
510
3616
1.96
20.90
5.7
5.9
%
28.6
28.7
0.10
482
3355
(3019069) Monocytes/100 leukocytes in Blood
499
3530
1.94
20.39
5.9
6.1
%
8.5
8.3
0.93
472
3294
(3006504) Eosinophils/100 leukocytes in Blood
497
3517
1.93
20.23
5.7
5.8
%
2.9
2.8
0.65
467
3254
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
725
5889
2.22
19.49
8.5
7.0
u/l
76.1
77.0
0.19
702
5520
(3018010) Neutrophils/100 leukocytes in Blood
501
3585
1.90
19.39
5.7
5.7
%
56.3
56.8
0.38
474
3340
(42870588) Differential panel, method unspecified - Blood
379
2479
1.92
19.32
5.4
5.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
533
3931
1.88
18.35
5.9
6.0
e9/l
0.2
0.2
0.91
460
3471
(3019198) Lymphocytes [#/volume] in Blood
526
3866
1.88
18.28
5.7
5.7
e9/l
1.9
1.9
0.62
461
3425
(3001604) Monocytes [#/volume] in Blood
515
3767
1.87
18.09
5.7
5.7
e9/l
0.6
0.6
0.08
442
3271
(3006315) Basophils [#/volume] in Blood
515
3784
1.85
17.66
5.7
5.7
e9/l
0.0
0.0
0.24
440
3288
(40758558) Short blood count panel - Blood
308
1958
1.87
16.55
7.2
6.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
147
723
2.24
16.08
2.3
2.1
nmol/l
367.8
372.9
0.12
136
665
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
34
78
4.49
13.89
3.6
4.7
u/ml
49.9
60.0
—
9
26
(3013707) Erythrocyte sedimentation rate by Westergren method
684
5710
1.84
13.26
4.7
4.1
mm/h
11.6
11.8
0.08
645
5273
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
130
3.51
12.75
1.7
2.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
854
7830
3.03
11.56
16.6
14.0
mmol/l
3.9
3.9
2.49
837
7606
(3019550) Sodium [Moles/volume] in Serum or Plasma
852
7803
2.96
11.54
16.4
13.9
mmol/l
139.8
139.7
0.91
837
7593
(3013826) Glucose [Moles/volume] in Serum or Plasma
532
4225
1.64
11.44
4.4
4.2
mmol/l
6.4
6.6
1.18
501
3935
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
398
2964
1.62
10.96
2.1
1.9
pmol/l
98.5
96.9
0.26
196
1462
(3021589) Normoblasts [#/volume] in Blood
436
3356
1.58
10.22
9.9
8.8
e9/l
0.0
0.0
0.35
349
2762
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
831
7594
2.34
10.00
13.8
12.6
mg/l
21.4
21.0
0.12
657
5916
(3037522) Nuclear Ab [Titer] in Serum
179
1102
1.78
10.00
1.3
1.3
titre
370.0
563.2
1.38
36
251
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
266
1853
1.62
9.29
1.4
1.2
u/ml
1.2
1.6
0.33
66
496
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
816
7442
2.11
9.23
5.0
4.4
mmol/l
5.8
5.9
0.09
772
6832
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
782
7036
1.89
9.11
6.0
5.4
mmol/mol
38.9
39.2
0.48
737
6540
(3007164) IgA [Mass/volume] in Serum or Plasma
234
1587
1.64
9.07
1.5
1.5
g/l
2.2
2.3
0.59
127
961
(36660697) Celiac disease serology panel - Serum
117
659
1.89
8.65
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
401
3118
1.52
8.43
4.0
4.2
g/l
36.0
35.9
0.14
373
2917
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
865
8152
2.88
7.90
13.7
10.0
u/l
23.9
25.1
1.63
850
7881
(3052851) Hemolysis interference index of Serum or Plasma
50
209
2.47
7.88
2.2
3.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
95
516
1.94
7.82
2.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
794
7272
1.82
7.42
13.6
11.5
ml/min/173m2
83.9
82.8
0.89
685
5942
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
818
1.74
7.33
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
530
1.89
7.22
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
196
1352
1.58
6.88
2.9
2.7
mmol/l
2.4
2.4
1.31
166
1192
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
45
194
2.39
6.67
1.2
1.2
u/ml
60.8
40.8
—
6
21
(3035637) Corticotropin [Mass/volume] in Plasma
25
79
3.23
6.61
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
596
5160
1.47
6.57
3.4
2.9
u/l
36.4
44.6
2.90
570
4834
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
46
3.97
6.46
5.8
7.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
257
1917
1.48
6.19
3.0
2.9
e6/l
0.3
0.4
1.21
186
1428
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
164
1124
1.56
5.85
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
185
1303
1.53
5.84
4.2
3.3
ng/l
233.6
294.3
0.13
140
931
(3018095) Leukocytes [#/volume] in Urine
321
2521
1.43
5.82
3.8
3.5
e6/l
62.9
84.5
0.50
208
1729
(3044640) Blood type and Crossmatch panel - Blood
300
2329
1.43
5.79
2.2
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
191
1359
1.52
5.74
2.8
2.6
mosm/kgh2o
544.3
534.1
0.24
152
1161
(3002385) Erythrocyte distribution width [Ratio]
711
6438
1.51
5.74
21.2
15.4
%
13.6
13.6
0.52
705
6304
(3012095) Magnesium [Moles/volume] in Serum or Plasma
164
1132
1.55
5.66
3.3
3.0
mmol/l
0.8
0.8
0.13
147
1057
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
20
63
3.22
5.34
1.2
1.1
nmol/l
1.3
1.0
—
6
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
1055
1.54
5.29
2.8
2.8
e6/l
4.4
3.6
0.26
80
537
(3044889) 12 lead EKG panel
601
5310
1.40
5.21
3.8
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
248
1896
1.43
5.10
3.1
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
232
1757
1.43
5.02
2.2
2.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
28
115
2.48
4.67
1.1
1.3
—
54.0
—
0
7
(3003458) Phosphate [Moles/volume] in Serum or Plasma
128
873
1.54
4.64
4.7
4.9
mmol/l
1.1
1.0
0.27
112
802
(3033658) Prothrombin time (PT) actual/Normal
238
1843
1.40
4.48
4.1
3.4
%
93.3
96.0
0.92
233
1789
(3037467) Urinalysis macro (dipstick) panel - Urine
586
5219
1.36
4.42
4.6
4.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
230
1781
1.39
4.31
2.6
2.1
mg/l
2.6
3.0
3.25
204
1507
(46235355) HIV 1 and 2 tests - Meaningful Use set
179
1328
1.43
4.27
1.7
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
877
8498
2.68
4.25
25.4
18.9
e9/l
262.0
258.2
1.06
858
8299
(3024731) MCV [Entitic volume]
877
8503
2.65
4.15
25.3
18.8
fl
91.0
90.9
0.39
870
8388
(3035941) MCH [Entitic mass]
877
8503
2.65
4.15
25.2
18.8
pg
30.2
30.2
0.20
870
8387
(3026361) Erythrocytes [#/volume] in Blood
877
8504
2.64
4.13
25.3
18.9
e12/l
4.5
4.5
3.09
856
8279
(3000963) Hemoglobin [Mass/volume] in Blood
877
8506
2.63
4.09
25.5
19.0
g/l
135.4
134.0
2.94
871
8390
(3010813) Leukocytes [#/volume] in Blood
877
8506
2.63
4.09
25.4
18.9
e9/l
6.6
6.6
0.02
857
8278
(3002582) Erythrocytes [#/volume] in Urine
262
2091
1.36
4.04
3.2
3.1
e6/l
36.4
86.6
0.76
191
1590
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
156
1142
1.44
3.99
2.7
2.6
e6/l
1.9
1.3
0.45
83
622
(40761511) CBC panel - Blood by Automated count
837
7998
1.73
3.96
15.3
11.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
77
485
1.64
3.91
2.8
2.8
ng/l
152.1
161.8
0.10
69
449
(3001122) Ferritin [Mass/volume] in Serum or Plasma
403
3441
1.31
3.86
3.5
2.8
ug/l
91.0
102.3
0.78
372
3197
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
102
690
1.54
3.84
2.2
2.2
u/l
28.2
38.8
2.17
86
580
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
270
1.82
3.64
1.6
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
51
2.97
3.58
1.9
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
304
2529
1.31
3.43
3.2
2.9
u/l
27.1
29.4
1.57
286
2414
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
182
1408
1.37
3.37
1.3
1.3
u/ml
7.4
11.5
0.39
57
561
(40768804) Tissue Pathology biopsy report
383
3291
1.29
3.36
2.1
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
115
821
1.46
3.36
2.1
2.5
umol/l
5.7
6.9
0.87
95
706
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
234
1.83
3.31
1.6
1.6
iu/ml
0.2
0.1
—
8
38
(3019309) Folate [Moles/volume] in Red Blood Cells
165
1266
1.37
3.21
1.6
1.7
nmol/l
1077.5
1196.5
1.07
121
933
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
559
5055
1.28
3.19
3.0
3.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
445
3915
1.27
3.17
5.5
5.7
umol/l
10.8
10.5
0.26
424
3706
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
41
237
1.77
2.90
1.7
1.6
—
166.7
—
0
9
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
186
1476
1.33
2.89
1.3
1.3
iu/ml
23.3
31.5
0.62
51
480
(3023323) Follitropin [Units/volume] in Serum or Plasma
68
453
1.54
2.79
1.3
1.3
iu/l
28.4
30.6
0.22
55
389
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
211
1.79
2.75
1.2
1.8
g/l
38.6
38.7
0.01
31
189
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
24
118
2.06
2.73
1.0
1.0
u/ml
2.2
2.0
—
7
51
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
15
4.69
2.60
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
102
749
1.41
2.58
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
114
2.04
2.58
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
372
1.57
2.58
1.4
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
183
1478
1.30
2.50
2.4
2.5
e6/l
7.0
7.2
0.06
149
1295
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
38
226
1.71
2.47
1.2
2.0
g/l
0.9
0.8
0.06
32
206
(3021960) Folate [Moles/volume] in Serum or Plasma
203
1665
1.28
2.46
1.4
1.5
nmol/l
20.0
21.8
1.15
176
1409
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
69
475
1.49
2.46
1.4
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
248
2088
1.26
2.42
1.7
1.7
mmol/l
1.3
1.4
0.57
212
1761
(3019225) pH of Specimen
100
741
1.39
2.42
5.6
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
75
530
1.45
2.35
3.2
3.0
e9/l
3.9
3.9
0.04
63
423
(3048689) Calprotectin [Mass/mass] in Stool
125
968
1.34
2.30
2.0
2.1
ug/g
117.8
112.6
0.04
100
752
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
399
3555
1.22
2.28
3.6
3.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
83
602
1.42
2.27
3.2
3.5
mmol/l
1.2
1.2
1.30
78
508
(3009542) Hematocrit [Volume Fraction] of Blood
738
7022
1.29
2.23
19.7
13.5
%
40.0
39.6
0.52
586
5160
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
80
2.15
2.19
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
79
573
1.42
2.17
2.2
3.0
g/l
9.8
10.3
0.59
74
532
(3022493) Free Hemoglobin [Mass/volume] in Plasma
7
19
3.70
2.15
2.0
6.7
mg/l
102.7
69.1
—
7
11
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
317
1.54
2.10
10.1
9.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
245
1.62
2.10
1.2
1.9
g/l
9.5
10.6
1.42
32
216
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
124
1.88
2.08
1.7
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
10
5.02
2.07
2.0
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
103
1.96
2.06
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
247
1.61
2.04
1.2
1.9
g/l
3.0
3.1
0.29
32
203
(3003327) Ova and parasites identified in Stool by Light microscopy
43
279
1.57
2.04
1.4
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
26
3.10
2.01
1.3
2.1
ug/l
38.3
53.2
—
8
26
(3009508) Creatinine [Moles/volume] in Urine
255
2195
1.23
2.00
2.8
3.0
mmol/l
7.1
7.1
0.06
216
1851
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
254
2186
1.23
2.00
2.2
2.1
u/l
160.9
190.1
0.27
231
2063
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
60
421
1.46
1.99
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
21
3.35
1.97
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
94
717
1.35
1.93
7.5
7.0
mmol/l
1.2
1.4
0.31
74
581
(3006462) Nitrate [Presence] in Urine
9
33
2.74
1.93
1.9
3.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
1076
1.29
1.92
1.9
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
109
856
1.31
1.84
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
46
311
1.51
1.84
1.6
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
130
1.79
1.83
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
130
1.79
1.83
1.2
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
12
4.18
1.82
4.6
1.5
u/l
307.6
373.5
—
5
12
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
223
1.59
1.81
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
23
3.06
1.80
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
202
1.61
1.73
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
202
1728
1.22
1.67
3.1
3.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
261
1.52
1.66
1.2
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
261
1.52
1.66
1.2
1.9
g/l
4.3
3.8
0.31
31
199
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
261
1.52
1.66
1.2
1.9
g/l
7.5
7.5
0.04
32
210
(3035350) Ketones [Presence] in Urine by Test strip
408
3722
1.18
1.64
3.4
3.6
estimate
0.0
0.0
0.00
75
692
(3025130) Human papilloma virus identified in Specimen
22
128
1.74
1.61
2.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
43
2.34
1.60
2.0
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
173
1463
1.23
1.60
1.5
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
264
2327
1.19
1.58
3.2
2.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
26
2.71
1.58
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
410
3753
1.17
1.56
4.9
4.8
estimate
0.0
0.0
0.50
78
695
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
801
7778
1.29
1.52
5.0
4.8
mmol/l
2.9
2.9
0.38
742
7200
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
123
1.72
1.52
1.6
1.5
—
—
—
0
0
(4034850)
14
256
0.54
1.51
10.8
9.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
21
2.87
1.50
1.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
568
1.33
1.50
3.2
4.3
%
0.0
0.8
0.63
15
128
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
72
1.96
1.49
1.6
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
413
3794
1.16
1.48
3.5
3.6
estimate
0.0
0.0
0.80
76
673
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
788
7642
1.26
1.47
4.3
4.3
mmol/l
4.8
4.8
0.18
735
7115
(40760892) CBC W Ordered Manual Differential panel - Blood
204
1770
1.20
1.45
4.8
4.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
304
2730
1.17
1.45
8.7
7.5
inr
1.2
1.2
0.36
75
819
(4211845)
9
39
2.32
1.43
1.9
3.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
39
2.32
1.43
1.0
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
119
979
1.25
1.43
2.5
2.2
g/l
2.4
2.4
0.26
109
906
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
126
1.68
1.41
1.2
1.2
u/ml
3.1
3.7
—
10
37
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
96
772
1.27
1.40
1.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
77
602
1.31
1.39
3.6
4.2
%
0.1
0.1
0.48
17
155
(3004588) Protein electrophoresis panel - Serum or Plasma
62
471
1.34
1.36
1.3
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
82
1.84
1.36
1.6
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
68
1.93
1.34
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
68
1.93
1.34
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
68
1.93
1.34
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
80
634
1.29
1.31
3.5
4.1
%
1.1
1.0
0.02
19
172
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
36
251
1.45
1.30
1.3
1.7
g/l
0.2
0.2
0.31
31
241
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
15
254
0.58
1.27
3.1
4.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
710
1.27
1.26
3.3
4.2
u/l
234.1
250.3
0.40
82
676
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
77
1.83
1.26
1.4
1.2
u/ml
0.1
0.9
—
8
28
(3020630) Protein [Mass/volume] in Serum or Plasma
71
558
1.30
1.25
1.4
2.8
g/l
66.0
67.4
0.83
62
515
(3051611) Lipemic interference index of Serum or Plasma
13
70
1.87
1.24
2.7
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
322
1.39
1.24
1.2
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
740
1.26
1.23
1.8
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
73
578
1.29
1.22
3.6
4.0
%
0.7
0.6
0.17
15
117
(3012516) Albumin [Mass/volume] in Urine
230
2048
1.17
1.20
2.9
3.2
mg/l
330.6
283.1
0.06
134
1232
(3022217) INR in Platelet poor plasma by Coagulation assay
95
779
1.25
1.20
16.3
20.9
inr
1.3
1.2
0.22
16
102
(3022948) Iron [Moles/volume] in Serum or Plasma
128
1084
1.21
1.19
2.6
2.3
umol/l
13.5
13.3
0.16
118
992
(4198724)
6
26
2.32
1.19
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
91
745
1.25
1.17
1.9
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
50
2.01
1.16
2.7
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
118
1.62
1.15
1.4
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
71
565
1.28
1.15
2.7
2.9
ug/l
0.7
0.8
0.20
44
345
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
233
2084
1.16
1.15
1.4
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
59
459
1.31
1.14
1.5
1.8
g/l
1.4
1.4
0.08
52
426
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
371
1.34
1.13
2.4
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
103
1.66
1.13
1.1
1.3
nmol/l
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
167
1.51
1.13
1.3
1.2
u/l
17.1
13.2
0.46
20
131
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
40
2.01
1.12
1.6
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
51
1.97
1.11
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
280
0.64
1.10
1.4
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
128
1.58
1.09
1.3
1.2
u/ml
2.7
5.3
0.60
15
49
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
270
1.39
1.08
1.6
1.8
g/l
1.5
1.5
0.10
28
234
(3023520) Reticulocytes [#/volume] in Blood
65
517
1.28
1.07
2.0
2.7
e9/l
75.1
72.5
0.19
41
391
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
780
7605
1.20
1.05
4.3
4.3
mmol/l
1.5
1.5
0.66
722
7040
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
36
263
1.38
1.05
1.3
1.7
g/l
1.2
1.2
0.27
31
250
(3000475) Leukocytes [#/volume] in Synovial fluid
24
162
1.49
1.05
2.0
1.6
e6/l
2657.0
15242.1
2.09
19
121
(3023368) Bacteria identified in Blood by Culture
195
1734
1.16
1.04
4.2
4.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
15
237
0.63
1.00
2.2
4.3
mmol/l
1.3
1.2
0.10
15
232
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
48
371
1.31
0.99
1.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
62
496
1.27
0.99
8.7
7.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
107
909
1.20
0.99
1.8
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
49
1.85
0.98
1.6
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
215
1.41
0.98
1.2
1.4
ug/g
272.9
305.6
0.35
17
126
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.1
—
40.4
—
0
7
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
37
276
1.36
0.97
1.7
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
108
922
1.19
0.95
1.8
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
84
701
1.22
0.93
2.1
2.8
%
1.7
1.8
0.91
79
615
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
192
1.42
0.93
1.4
3.6
mg/l
34.5
40.8
0.39
20
152
(3016018) Differential panel - Cerebral spinal fluid
13
78
1.68
0.92
1.2
1.6
—
—
—
0
0
(4094501)
27
193
1.41
0.91
1.0
1.1
—
—
—
0
0
(3013512) EKG study
232
2110
1.13
0.90
3.5
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
127
1.51
0.89
1.4
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
106
910
1.19
0.89
2.8
2.3
%
22.2
22.7
0.13
83
775
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
56
1.79
0.88
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
237
2162
1.13
0.88
3.6
3.9
mg/mmol
6.0
6.3
0.06
130
1295
(3023410) Appearance of Cerebral spinal fluid
14
87
1.62
0.88
1.5
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
256
1.34
0.86
1.6
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
44
1.83
0.86
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
58
470
1.25
0.86
1.5
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
194
1751
1.14
0.85
2.1
1.7
mg/l
0.9
1.0
0.41
142
1343
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
599
0.79
0.84
2.2
2.4
ml/min/173m2
68.0
67.9
0.01
22
239
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
154
1.44
0.84
2.6
3.7
%
60.5
57.8
0.35
22
154
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
266
1.33
0.84
1.1
1.3
miu/ml
198.6
240.6
0.27
18
125
(1616796) Gas panel - Central venous blood
8
137
0.58
0.84
6.0
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
113
982
1.17
0.83
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
116
1011
1.17
0.82
2.2
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
257
2366
1.12
0.82
2.7
2.3
u/l
52.9
56.7
1.22
241
2192
(3028433) Virus identified in Specimen by Culture
6
32
1.88
0.82
1.0
1.3
—
—
—
0
0
(3012544) pH of Venous blood
71
593
1.21
0.81
3.1
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
207
1.36
0.80
2.3
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
495
0.78
0.79
1.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
106
1.52
0.79
2.0
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
33
1.82
0.79
1.8
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
148
1.43
0.78
2.6
3.3
e9/l
4.8
4.2
0.40
21
148
(1617658) Protocol used for examination of sentinel lymph nodes
5
97
0.51
0.78
1.0
1.1
—
—
—
0
0
(4268621)
13
82
1.59
0.78
2.4
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
69
577
1.21
0.78
2.8
3.2
mmol/l
2.2
2.2
0.02
41
468
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
123
1.47
0.78
1.0
1.0
u/ml
0.5
2.0
0.70
12
46
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
34
1.77
0.76
1.2
1.1
miu/ml
1675.0
1705.1
—
6
34
(3043409) Potassium [Moles/volume] in Arterial blood
14
209
0.66
0.76
2.3
4.2
mmol/l
3.9
3.8
0.20
14
195
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
26
192
1.36
0.75
1.5
3.6
mg/l
30.4
43.3
0.36
19
150
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
9
54
1.67
0.74
1.1
1.3
—
21.3
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
184
1.37
0.74
2.8
2.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
26
193
1.36
0.74
1.2
1.2
—
69.0
—
0
20
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
25
2.01
0.72
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
92
1.53
0.72
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
264
0.71
0.72
1.4
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
117
1.46
0.72
1.2
1.4
u/ml
331.0
111.1
—
6
29
(3003740) Influenza virus B Ag [Presence] in Specimen
19
134
1.43
0.71
1.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
25
186
1.35
0.70
1.5
3.6
—
1.9
—
0
20
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
143
0.63
0.70
1.2
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
169
0.65
0.69
1.4
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
42
1.67
0.68
1.0
1.1
—
10.3
—
0
6
(3034770) Mitochondria Ab [Titer] in Serum
27
205
1.33
0.68
1.2
1.2
—
1121.0
—
0
10
(3004616) Nuclear Ab [Presence] in Serum
15
102
1.48
0.68
1.4
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
37
295
1.27
0.66
2.6
2.9
mmol/l
24.9
24.4
0.55
37
268
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
128
1.41
0.66
1.0
1.0
u/ml
2.3
3.0
0.30
12
56
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
164
1.35
0.63
5.0
2.5
u/ml
0.4
0.4
—
7
88
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
31
245
1.27
0.60
1.2
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
22
0.00
0.59
0.0
1.2
—
4.4
—
0
17
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
246
1.27
0.59
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
35
1.72
0.57
1.8
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
54
1.49
0.57
1.3
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
67
580
1.17
0.56
2.7
3.2
kpa
5.6
5.9
1.03
58
569
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
82
929
0.87
0.56
6.9
6.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
221
1.28
0.56
1.3
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
37
1.63
0.55
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
74
647
1.16
0.55
4.7
3.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
38
1.58
0.54
1.5
2.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
99
1.42
0.54
2.3
2.8
—
678.4
—
0
8
(3025941) Bacteria identified in Stool by Culture
51
433
1.19
0.53
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
74
1.49
0.53
2.1
3.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
108
1.40
0.53
1.1
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
134
1.35
0.53
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
250
1.25
0.53
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
284
2685
1.08
0.52
2.8
3.4
ng/l
23.7
44.3
0.74
149
1720
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
179
1.29
0.51
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
135
1.34
0.51
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
92
822
1.13
0.51
1.8
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
75
1.47
0.51
1.3
1.4
g/l
0.5
0.3
0.91
11
56
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
75
1.47
0.51
1.3
1.4
g/l
2.7
2.7
0.01
11
55
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
75
1.47
0.51
1.3
1.4
g/l
5.9
7.1
0.82
11
57
(3040151) Glucose [Moles/volume] in Capillary blood
9
65
1.39
0.50
1.6
9.6
mmol/l
9.0
6.7
—
9
52
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
41
1.47
0.50
1.5
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.5
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.5
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
189
1.28
0.50
1.5
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
45
1.56
0.49
1.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
718
0.87
0.48
1.7
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
155
1.30
0.47
1.7
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
187
1998
0.92
0.46
3.8
4.0
estimate
0.0
0.0
1.08
79
685
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
94
1.39
0.46
1.2
2.3
umol/l
3.5
5.5
—
8
65
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
129
1.32
0.46
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
86
772
1.13
0.45
3.5
4.1
%
21.5
21.5
0.01
33
347
(3027944) Amphetamines [Presence] in Urine
29
238
1.23
0.44
1.4
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
51
1.38
0.44
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
746
7346
1.09
0.44
3.9
3.8
mmol/l
1.2
1.3
0.48
683
6761
(4062490)
11
78
1.42
0.43
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
56
1.43
0.42
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
56
1.43
0.42
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
30
249
1.21
0.42
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
106
969
1.11
0.42
4.6
4.7
ug/l
2.7
2.3
0.29
93
855
(3000764) Benzodiazepines [Presence] in Urine
29
240
1.22
0.42
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
33
1.52
0.41
1.2
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
33
1.52
0.41
1.2
1.6
nmol/l
97.0
153.1
—
5
33
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
48.3
—
0
6
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
25
204
1.23
0.41
6.2
2.1
%
177.4
175.3
0.05
25
195
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
123
1.31
0.40
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
101
0.69
0.39
1.6
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
124
1.30
0.39
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
225
1.21
0.37
1.4
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.7
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
115
0.69
0.37
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
143
1.26
0.37
1.0
1.1
u/ml
0.7
2.6
0.99
11
51
(3032773) Endomysium IgG Ab [Titer] in Serum
11
81
1.36
0.36
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.1
—
61.9
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.1
—
43.2
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
77
0.65
0.36
6.0
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
78
0.64
0.35
3.0
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
442
1.14
0.35
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
153
1628
0.93
0.35
3.5
4.0
kg/l
1.0
1.0
0.08
22
219
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
123
0.73
0.35
1.0
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
73
1.37
0.34
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
719
0.90
0.34
2.8
4.1
ug/l
11.4
15.4
0.22
51
579
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
44
1.37
0.34
2.0
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
280
2914
0.94
0.34
3.8
3.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
173
1.22
0.33
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
198
1882
1.07
0.33
2.5
2.8
ng/l
1031.2
878.1
0.24
167
1566
(40761535) Cells panel - Urine sediment
53
591
0.89
0.32
4.3
3.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
211
1.19
0.31
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
211
1.19
0.31
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
174
1.21
0.31
1.3
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
97
0.72
0.31
1.3
1.9
u/ml
6.1
46.0
—
7
90
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
147
1.23
0.31
2.0
2.2
g/l
132.5
129.9
0.17
13
105
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
212
1.18
0.30
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
212
1.18
0.30
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
240
1.17
0.30
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
184
1751
1.06
0.30
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
130
0.77
0.29
2.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
148
1.22
0.29
1.4
4.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
241
1.17
0.29
1.4
1.4
—
—
—
0
0
(4010399)
60
546
1.11
0.28
1.7
1.5
—
—
—
0
0
(44813793)
8
62
1.29
0.28
1.3
1.0
—
—
—
0
0
(3036489) Thrombin time
31
271
1.15
0.27
3.7
1.8
s
21.5
21.1
0.25
31
239
(3023511) Choriogonadotropin [Units/volume] in Urine
20
168
1.19
0.27
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
195
1866
1.06
0.27
2.3
2.4
umol/l
6730.8
4852.5
0.20
176
1608
(4146454)
8
67
1.20
0.26
3.8
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
71
0.70
0.26
1.2
3.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
9
72
1.25
0.25
1.1
1.1
—
83.9
—
0
6
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
22
188
1.17
0.25
2.3
3.8
u/ml
15.7
34.6
1.92
22
183
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
22
255
0.86
0.24
1.1
1.4
pmol/l
75.0
213.4
1.34
22
250
(3037121) Protein [Mass/volume] in Urine
27
236
1.15
0.24
2.3
3.2
g/l
0.1
0.2
1.31
16
77
(44790047)
11
87
1.27
0.24
2.5
1.5
—
—
—
0
0
(44806118)
11
87
1.27
0.24
2.5
1.5
—
—
—
0
0
(44790048)
11
87
1.27
0.24
2.5
1.5
—
—
—
0
0
(44790049)
11
87
1.27
0.24
2.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
45
408
1.11
0.24
3.1
3.3
ph
7.4
7.4
—
8
56
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
743
0.92
0.24
3.1
3.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
97
1.24
0.23
1.0
1.1
u/ml
0.0
3.3
—
6
29
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
368
0.89
0.22
1.7
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
347
0.89
0.22
3.2
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
116
1.21
0.22
1.4
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
11.2
—
0
5
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
98
1.23
0.21
2.3
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
98
1.23
0.21
1.0
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
0.5
—
0
7
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(4281824)
8
102
0.78
0.21
1.3
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
162
1557
1.05
0.20
1.6
1.7
pmol/l
86525247.8
26137677.3
0.48
141
1297
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
1.7
—
0
14
(3024928) Oxygen saturation in Venous blood
16
136
1.18
0.20
1.9
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
90
1.22
0.19
1.5
3.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
37
337
1.10
0.19
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
46
424
1.09
0.19
4.4
4.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
277
2842
0.96
0.19
2.5
2.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
2.9
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
60
1.17
0.18
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
91
1.21
0.17
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
291
1.10
0.17
1.5
2.0
u/l
213.5
3584.8
—
10
119
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
62
1.13
0.17
3.1
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
152
0.85
0.17
1.2
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
98
936
1.05
0.16
4.7
4.4
%
33.6
33.0
0.22
69
626
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
329
0.91
0.16
1.7
1.7
mg/l
2.5
4.6
0.58
20
232
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
93
887
1.05
0.16
1.3
1.7
%
1.4
1.4
0.14
81
782
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
25
225
1.11
0.16
4.3
1.8
%
94.3
94.5
0.02
25
210
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
206
1.12
0.16
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
72
1.11
0.16
1.3
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
213
2073
1.04
0.16
3.4
3.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
108
1036
1.05
0.15
3.3
1.8
s
30.7
29.5
0.65
102
1001
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
140
0.86
0.15
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
102
1.18
0.15
1.1
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
362
1.08
0.14
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
83
1.09
0.14
1.3
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
112
1.16
0.14
1.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
179
1.12
0.14
1.9
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
96
0.83
0.13
2.5
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
31
335
0.92
0.13
1.5
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
106
0.85
0.13
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
142
1.13
0.12
1.1
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
562
1.05
0.11
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
298
1.08
0.11
3.6
3.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
146
0.89
0.10
4.0
3.9
mg/l
34.7
24.1
—
6
86
(40768797) Stomach Pathology biopsy report
118
1147
1.03
0.10
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
70
673
1.04
0.10
2.3
2.1
g/l
0.2
0.2
0.24
63
632
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
135
0.89
0.10
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(4306422)
13
116
1.12
0.09
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(4035726)
68
657
1.04
0.08
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
60
0.83
0.08
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
40
381
1.05
0.08
1.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
64
0.78
0.08
1.0
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
76
784
0.97
0.08
1.3
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
88
1.14
0.08
2.1
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
156
1.09
0.08
1.4
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
50
480
1.04
0.08
2.3
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
70
0.86
0.07
1.5
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
73
0.82
0.07
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
186
1.08
0.07
1.4
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
16
147
1.09
0.07
2.3
2.7
kpa
7.4
8.1
0.83
11
139
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
81
0.86
0.07
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
84
0.83
0.07
3.1
2.2
pg
32.0
32.3
—
7
84
(3024354) Oxygen [Partial pressure] in Venous blood
49
472
1.04
0.07
2.6
2.6
kpa
5.1
4.6
1.18
44
460
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
216
1.07
0.07
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
216
1.07
0.07
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
119
1.09
0.06
1.6
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
71
727
0.97
0.05
1.4
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
171
0.93
0.05
1.6
2.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
109
0.92
0.04
2.7
1.7
nmol/l
53.6
43.5
—
10
104
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
139
0.93
0.03
2.1
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
171
1.05
0.03
1.9
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
112
1.07
0.03
1.2
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
390
1.03
0.03
3.0
3.3
mmol/l
1.8
1.9
0.01
31
292
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
178
0.95
0.02
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
188
0.96
0.02
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
212
1.04
0.02
3.1
2.4
—
—
—
0
0
(1002224) Polysomnography panel
34
348
0.98
0.01
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
127
0.94
0.01
2.2
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
418
0.98
0.01
1.4
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
548
0.98
0.01
2.1
2.3
ug/l
6.3
5.8
0.10
44
485
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
214
1.03
0.00
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
766
0.99
0.00
1.9
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
124
0.97
0.00
1.3
1.2
u/ml
307.3
254.4
—
7
77
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
124
0.97
0.00
2.3
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
126
1.03
0.00
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
166
1.02
0.00
5.7
4.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
98
1.02
0.00
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
98
1.02
0.00
1.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
85
855
0.99
0.00
2.0
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
117
1.03
0.00
1.5
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
14
137
1.02
0.00
3.4
3.7
u/ml
172.2
2125.9
0.57
14
129
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
153
0.98
0.00
2.0
2.4
ug/min
9.1
84.6
—
10
91
(3020779) Urea [Moles/volume] in Serum or Plasma
54
541
1.00
0.00
8.1
6.7
mmol/l
8.7
8.7
0.00
47
519
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
173
0.98
0.00
1.4
1.5
e6/l
11.3
9.9
—
10
134
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
173
0.98
0.00
1.4
1.5
e6/l
681.3
138.7
0.37
11
138
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
99
1.01
0.00
1.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
11
109
1.01
0.00
1.1
1.2
u/l
13.7
20.7
0.62
11
93
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
171
0.99
0.00
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
99
1.01
0.00
1.0
1.4
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
6.5
—
0
8
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
8.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
1.2
1.5
g/l
0.8
1.0
—
5
58
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.9
—
0
5
(3027456) Digoxin [Moles/volume] in Serum or Plasma
9
98
0.92
0.00
3.8
3.2
nmol/l
1.0
0.8
—
9
73
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
343.6
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.5
—
0
5
(21494815) CD4 cells/100 lymphocytes in Specimen
5
55
0.91
0.00
2.8
1.7
—
41.0
—
0
9
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
100
1.00
0.00
1.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
120
1.00
0.00
1.3
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.6
—
0.2
—
0
9
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
94
0.96
0.00
1.2
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.9
—
0
7
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.9
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
52
0.96
0.00
1.0
1.7
%
14.4
11.0
—
5
52
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.9
—
0
6
(3006270) Folate [Moles/volume] in Blood
6
61
0.98
0.00
1.0
1.1
nmol/l
335.0
393.9
—
6
56
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
66
0.91
0.00
1.3
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
80
1.00
0.00
1.5
2.3
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.7
—
0
7
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
100
1.00
0.00
1.0
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
69
0.87
0.00
1.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
79
1.01
0.00
1.4
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
54
0.93
0.00
1.2
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint GRAVES_OPHT and mortality.

Females

Parameter HR [95% CI] p-value
GRAVES_OPHT 0.959 [0.83, 1.1] 0.558
Birth year 0.994 [0.99, 1.0] 0.163

During the follow-up period (1.1.1998 — 31.12.2019), 269 out of 3299 females with GRAVES_OPHT died.

Males

Parameter HR [95% CI] p-value
GRAVES_OPHT 0.932 [0.75, 1.16] 0.532
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 104 out of 762 males with GRAVES_OPHT died.

Mortality risk

Mortality risk for people of age

years, who have GRAVES_OPHT.

N-year risk Females Males
1 0.083% 0.178%
5 0.592% 1.02%
10 1.423% 2.475%
15 2.785% 4.756%
20 4.852% 8.199%

Relationships between endpoints

↥

Index endpoint: GRAVES_OPHT – Graves ophthalmopathy

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data